You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 147 No. 5, May 1987 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (106)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Sicca Complex and Infection With Human Immunodeficiency Virus

Louis-Jean Couderc, MD; Marie-Françoise D'Agay, MD; Françoise Danon, MD; Martine Harzic, MD; Claude Brocheriou, MD; Jean-Pierre Clauvel, MD

Arch Intern Med. 1987;147(5):898-901.


Abstract



• Five male patients with the persistent generalized lymphadenopathy syndrome also had a sicca complex. Salivary gland biopsy specimens showed diffuse lymphocytic infiltration of the glandular parenchyma. Serum autoantibodies and rheumatoid factor were not detected. All patients had IgG antibodies to human immunodeficiency virus and IgG to the viral capsid antigen of Epstein-Barr virus. These five patients had benign lymphocytic infiltrates in other organs (lung, liver, and kidneys). Sicca complex may be one of the various manifestations of the lymphoid hyperplasia noted in human immunodeficiency virus—infected patients. In these patients, the sicca complex showed specific features related to male predominance, lack of serum autoantibodies, and peripheral-blood T-lymphocyte subset distribution.

(Arch Intern Med 1987;147:898-901)



Author Affiliations



From the Departments of Immunology and INSERTA 4108 (Drs Couderc, Danon, and Clauvel), Pathology (Drs D'Agay and Brocheriou), and Virology (Dr Harzic), St Louis Hospital, Paris.


Footnotes



Accepted for publication Oct 22, 1986.

Reprint requests to Hôpital St Louis, 1, avenue Claude Vellefaux, 75475 Paris Cedex 10, France (Dr Clauvel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lamivudine is not effective in primary Sjogren's syndrome
Gescuk et al.
Ann Rheum Dis 2005;64:1326-1330.
ABSTRACT | FULL TEXT  

Zidovudine in primary Sjogren's syndrome
Steinfeld et al.
Rheumatology (Oxford) 1999;38:814-817.
ABSTRACT | FULL TEXT  

Questions and Answers
Wolff
Arch Ophthalmol 1990;108:1224-1224.
 

Tumoral Nasopharyngeal Lymphoid Hyperplasia in Human Immunodeficiency Virus-Infected Patients
Oksenhendler et al.
Arch Intern Med 1989;149:2359-2361.
ABSTRACT  

Rheumatologic Manifestations of Infection with Human Immunodeficiency Virus (HIV)
Kaye
ANN INTERN MED 1989;111:158-167.
ABSTRACT  

Cystic Parotid Lesions in Patients at Risk for the Acquired Immunodeficiency Syndrome
Finfer et al.
Arch Otolaryngol Head Neck Surg 1988;114:1290-1294.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.